<DOC>
	<DOCNO>NCT02484898</DOCNO>
	<brief_summary>The purpose Medtronic SEEQ™ Performance study build evidence clinical economic benefit Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System ( MCT/ECM ) .</brief_summary>
	<brief_title>SEEQ™ Performance Study</brief_title>
	<detailed_description />
	<criteria>Patient indicate SEEQ™ MCT/ECM System approve indication Patient 18 year age old Patient willing able provide consent authorize use disclosure health information Patient willing able comply protocol Patient know allergy and/or hypersensitivity adhesives hydrogel . Patient suspect potential lifethreatening arrhythmia , require insubject/inhospital monitoring . Patient undergo medical procedure would preclude full participate prescribe duration SEEQ™ Patient implant cardiac device , ( e.g. , pacemaker , Implantable Cardioverter Defibrillator , Cardiac Resynchronization Therapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>